Literature DB >> 10457737

Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

K Stavem1.   

Abstract

The objective of the study was to evaluate the reliability, validity and responsiveness of two generic multiattribute methods for measuring utility for health states: a 15-dimensional (15D) and a five-dimensional method (EuroQol and EQ-TTO). A self-administered questionnaire with both measures was used in 59 outpatients with chronic obstructive pulmonary disease and the findings compared with standard gamble (SG) and time trade-off (TTO) utilities, spirometry and arterial blood gases. Quality of life scores were smallest for EQ-TTO (median 0.73) and highest for SG and TTO (median 0.91 and 0.95 respectively), while 15D gave intermediate values (median 0.80). The test-retest reliability over 14 days was: 15D (p = 0.90) and EQ-TTO (p = 0.73), using Spearman's rank correlation. 15D was better than EQ-TTO at discriminating between groups of patients after reported global rating of change over 12 months (P = 0.004 versus P = 0.09), indicating that 15D was more responsive. The 15D instrument has many attractive properties when compared to the EQ-TTO method, including a better reliability and responsiveness. Validity depends on validation method. The findings in this study indicate that the different utility measures measure different aspects of health-related quality of life (HRQoL). Caution should be taken when choosing utility instruments in cost-utility studies, as this can strongly influence the results.

Entities:  

Mesh:

Year:  1999        PMID: 10457737     DOI: 10.1023/a:1026475531996

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  40 in total

1.  A scale for the measurement of quality of life in adults with asthma.

Authors:  G B Marks; S M Dunn; A J Woolcock
Journal:  J Clin Epidemiol       Date:  1992-05       Impact factor: 6.437

2.  Functional status versus utilities in survivors of myocardial infarction.

Authors:  J Tsevat; L Goldman; G A Lamas; M A Pfeffer; C C Chapin; K F Connors; T H Lee
Journal:  Med Care       Date:  1991-11       Impact factor: 2.983

3.  Quality of life in epilepsy: comparison of four preference measures.

Authors:  K Stavem
Journal:  Epilepsy Res       Date:  1998-02       Impact factor: 3.045

Review 4.  Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice.

Authors:  E Nord
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

5.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

Review 6.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

7.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

8.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.

Authors:  C R McGavin; M Artvinli; H Naoe; G J McHardy
Journal:  Br Med J       Date:  1978-07-22

9.  Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.

Authors:  M P Rutten-van Mölken; F Custers; E K van Doorslaer; C C Jansen; L Heurman; F P Maesen; J J Smeets; A M Bommer; J A Raaijmakers
Journal:  Eur Respir J       Date:  1995-06       Impact factor: 16.671

10.  Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD.

Authors:  D A Mahler; J I Mackowiak
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

View more
  42 in total

1.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

Authors:  B Conner-Spady; C Cumming; J M Nabholtz; P Jacobs; D Stewart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

Authors:  Taru Kantola; Suvi Mäklin; Anna-Maria Koivusalo; Pirjo Räsänen; Anne Rissanen; Risto Roine; Harri Sintonen; Krister Höckerstedt; Helena Isoniemi
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

3.  The effect of different methods of collecting data: mail, telephone and filter data collection issues in utility measurement.

Authors:  Graeme Hawthorne
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

4.  Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.

Authors:  J Hahl; H Hämäläinen; H Sintonen; T Simell; S Arinen; O Simell
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

5.  Does septoplasty enhance the quality of life in patients?

Authors:  Maija L Hytönen; Markus Lilja; Antti A Mäkitie; Harri Sintonen; Risto P Roine
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

Review 6.  Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.

Authors:  Maureen P M H Rutten-van Mölken; Lucas M A Goossens
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

7.  Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients.

Authors:  Lene Lunde
Journal:  Eur J Health Econ       Date:  2012-06-08

8.  Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.

Authors:  K Aro; L Bäck; V Loimu; K Saarilahti; S Rogers; H Sintonen; R Roine; Antti Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-28       Impact factor: 2.503

9.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

10.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.